During the past decade, Herman Clinical Research, LLC conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 6 clinical trials were completed, i.e. on average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Herman Clinical Research, LLC" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "Bayer" with 1 trials sponsored, "Brigham and Women's Hospital" with 1 trials sponsored and "Edifice Health" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Herman Clinical Research, LLC" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator, "The Cleveland Clinic" with 1 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Herman Clinical Research, LLC" are "Cardiovascular Disease" (2 trials), "Obesity" (2 trials), "Overweight" (2 trials), "Arthritis, Rheumatoid" (1 trials) and "Chronic Disease" (1 trials). Many other conditions were trialed in "Herman Clinical Research, LLC" in a lesser frequency.

Most popular intervention types in "Herman Clinical Research, LLC" are "Drug" (9 trials), "Biological" (1 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Acarbose" (1 trials), "Dietary supplement" (1 trials), "Exenatide once weekly (QW)" (1 trials) and "Exenatide twice daily (BID)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Herman Clinical Research, LLC" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Herman Clinical Research, LLC". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Herman Clinical Research, LLC, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Herman Clinical Research, LLC, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".